Globus Medical, Inc.GMEDNYSE
Loading
EV/EBITDA Over TimeContracting
Percentile Rank43
3Y CAGR-13.4%
5Y CAGR-14.8%
Year-over-Year Change
Enterprise value to EBITDA ratio
3Y CAGR
-13.4%/yr
vs +6.4%/yr prior
5Y CAGR
-14.8%/yr
Consistent
Acceleration
-19.8pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 15.61 | -32.7% |
| 2024 | 23.18 | +32.1% |
| 2023 | 17.54 | -27.0% |
| 2022 | 24.03 | -10.1% |
| 2021 | 26.74 | -22.9% |
| 2020 | 34.71 | +41.2% |
| 2019 | 24.59 | +31.1% |
| 2018 | 18.75 | +0.4% |
| 2017 | 18.68 | +56.3% |
| 2016 | 11.95 | - |